Amgen buys deCODE genetics for $415mm in cash

Dec 2012

Amgen Inc. has acquired closely held human genetics firm deCODE genetics EHF for $415mm in cash.

Biotechnology
- Drug Discovery Tools
  - Genomics-Proteomics
- Pharmacogenetics-Pharmacogenomics
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing

Acquisition
- Full Acquisition
- Acquisition of Private Biotech
- Payment Includes Cash

Already a Strategic Transactions subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com

Related Companies

Amgen buys deCODE genetics for $415mm in cash

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice